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Abstract: Preeclampsia (PE) is characterized by the onset of hypertension (≥140/90 mmHg) and
presence of proteinuria (>300 mg/L/24 h urine) or other maternal organ dysfunctions. During
human PE, renal injuries have been observed. Some studies suggest that women with PE diagnosis
have an increased risk to develop renal diseases later in life. However, in human studies PE as a
single cause of this development cannot be investigated. Here, we aimed to investigate the effect of
PE on postpartum renal damage in an established transgenic PE rat model. Female rats harboring
the human-angiotensinogen gene develop a preeclamptic phenotype after mating with male rats
harboring the human-renin gene, but are normotensive before and after pregnancy. During pregnancy
PE rats developed mild tubular and glomerular changes assessed by histologic analysis, increased
gene expression of renal damage markers such as kidney injury marker 1 and connective-tissue
growth factor, and albuminuria compared to female wild-type rats (WT). However, four weeks
postpartum, most PE-related renal pathologies were absent, including albuminuria and elevated
biomarker expression. Only mild enlargement of the glomerular tuft could be detected. Overall, the
glomerular and tubular function were affected during pregnancy in the transgenic PE rat. However,
almost all these pathologies observed during PE recovered postpartum.
Keywords: preeclampsia; kidney injury; postpartum; transgenic rat model
1. Introduction
Preeclampsia (PE) affects about 5–8% of all pregnancies worldwide, with a high
maternal mortality rate due to complications such as eclampsia, HELLP-syndrome, or
edema [1–3]. According to the International Society for the Study of Hypertension in
Pregnancy, PE is characterized by the development of gestational hypertension (resting
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systolic blood pressure (BP) ≥ 140 and/or diastolic ≥ 90 mmHg) at or after 20 weeks of
gestation in previously normotensive women [1]. Since proteinuria is present in only 75%
of all cases [4], the American College of Obstetrics and Gynecology adapted guidelines for
PE established in 2019 stated that “either proteinuria (>300 mg/L per 24-h urine) or other
maternal organ dysfunction” should be present [1,5]. The underlying pathology of PE is
not yet fully understood but a placental origin featuring immunological dysfunctions and
vascular alterations plays an important role with a consequence of substantial long-term
cardiovascular and metabolic risk to mothers and children [6–9]. Various studies report
that PE is not only associated with acute kidney injury but can lead to substantial renal
disease and failure postpartum as well as later in life [10–12]. The renal injury during
human PE was first described by Spargo et al. as glomerular endotheliosis, meaning
enlarged glomeruli with destruction of the capillary lumen [13], attributed to hypertrophy
of endothelial or mesangial cells [14]. The presence of glomerular sclerosis, occlusion of
capillaries due to thickening of the glomerular capillary wall, infiltration of macrophages,
and reduced density of the endothelial fenestrae have been described in preeclamptic
women [15–18]. These structural changes as well as vasoconstriction and reduced plasma
volume contribute to a diminished renal filtration capacity [15,19]. The structural renal
injury present during preeclamptic pregnancies seems to be reversible [19], whereas a
functional impact is present postpartum and an association of PE and the risk for the
development of end-stage renal disease (ESRD) later in life has been reported [20,21].
There is evidence that an undetected chronic hypertension prior to the occurrence of a
preeclamptic pregnancy contributes to the increased risk for renal disease postpartum in
humans [12,20,21].
The renal injury during PE pregnancies has been characterized in many animal models.
Involved mechanisms in glomerular alterations include an angiogenic imbalance [9,22–24].
In the reduced uterine perfusion pressure (RUPP) rat model for PE, the renal impairment
could be restored by vascular endothelial growth factor (VEGF) treatment [25,26]. Further,
an important mechanism in preeclamptic renal injury seems to be an increased oxidative
and inflammatory stress, leading to increased reactive oxygen species (ROS) production and
complement activation [27–30]. Although these mechanisms cause severe renal alterations
during pregnancies, there is lack of knowledge whether renal impairment is present
postpartum in the PE animal model. There have been only few animal studies focusing
on postpartum renal damage. In the RUPP model, mean arterial blood pressure and
albuminuria were restored eight weeks after delivery. No glomerular or tubular damage
was present but the glomerular filtration rate was reduced [31].
The objective of this study was to assess the postpartum effects of PE on the kidneys in
a human renin-angiotensinogen transgenic rat model. In this model female rats transgenic
for human angiotensinogen had normal blood pressure before and after pregnancy. They
developed hypertension during the last third of pregnancy only upon mating to male rats
hosting the human renin gene, as described before [32,33]. Dams developed a preeclamptic
phenotype during pregnancy [34], including cardiac remodeling postpartum [35]. We
hypothesized that long-term renal injury, described for PE in humans and rodent models,
is mediated by high blood pressure (hypertensive crisis) during preeclamptic pregnancy
and restores postpartum.
2. Results
2.1. Preeclamptic Phenotype in the Transgenic Rat Model
Pregnant transgenic female rats exhibited symptoms of PE (Figure 1A), whereas WT
rats did not develop these symptoms. BP during preeclamptic pregnancy rose from day
12 to 14, following a plateau and decreased to normotensive values within two days after
pregnancy. The blood pressure remained normotensive until the end of the study and four
weeks postpartum (Figure 1B). WT rats were measured on single days (d0, 9, 15, 19, 28, 35,
42, 49) to enable comparison. The mean arterial blood pressure was at 105.3 ± 4.6 mmHg
in WT rats during pregnancy and at 148.4 ± 20.7 mmHg in preeclamptic pregnant rats,
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respectively. It was significantly elevated in preeclamptic pregnancy (wild type, WTd19
vs. PEd19; p < 0.0001) and normalized postpartum (PEd19 vs. PEd49, p < 0.0001; Figure 1C).
PE rats showed significantly higher urinary albumin relative to urinary creatinine during
pregnancy than WT (WTd21 vs. PEd21, p = 0.0024), and albumin excretion was restored
postpartum in PE rats (PEd21 vs. PEd49, p = 0.0004; Figure 1D). Although urinary albumin
was higher in WT rats postpartum compared to PE rats, there was no significant difference
(WTd49 vs. PEd49, p = 0.4917). There was an overall effect of PE on the albumin level at
different timepoints (2w-ANOVA: F(1;29) = 16.15; p = 0.0004).
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Figure 1. Hypertension developed during pregnancy in a preeclamptic rat model. (A) Female Sprague–Dawley rats
transgenic for the human angiotensinogen gene (Tg(Agt)) were mated with male Sprague–Dawley rats transgenic for the
human renin gene (Tg(Ren)). Thereafter, female rats developed a preeclamptic phenotype (PE). Sprague– a ley ild-type
r ts ( ) re te , fe ales ser e as a c trol. ( ) l ill tr ti f t r f t rt ri l l
ress r i a T over a period of 49 days, including preg ancy. It rose from day 12 to a maxi um of
170 mmHg and recurred shortly after pregna cy in preeclamptic dams. Control rats di not develop hypertension. All
values are presented as mean± SD (n = 5–9). Timepoints of metabolic cage and sacrifice are indicated. (C) PE rats developed
hypertension during pregnancy, mean arterial blood pressure was significantly increased (day 19) compared to WT and
recovered postpartum (day 49). (D) Albuminuria was detected as elevated urine albumin to creatinine ratio (n = 8) in
preeclamptic rats during (day 19) and after pregnancy (day 49) compared to pregnant WT. A statistical analysis was not
conducted for the course of blood pressure. Statistical analysis was performed using a two-way ANOVA. Bars are shown as
mean ± SD (n = 8–11). p-value is shown as ** p ≤ 0.01; *** p ≤ 0.001; **** p ≤ 0.001 (between groups).
As shown in one of our previous studies, preeclamptic rats showed reduced placental
and fetal body weight compared to control rats [35], whereby maternal body weight was
reduced at the end of gestation. The mean kidney weight between transgenic and WT
rats was similar during (WTd21 = 0.8 g ± 0.06; PEd21 = 0.7 g ± 0.07) and after pregnancy
(WTd50 = 0.9 g ± 0.05; PEd50 = 1.0 g ± 0.06) (Figure S1A). Kidney weight normalized to
maternal body weight showed significant higher values in the PE group compared to WT
(WTd21 vs. PEd21 p = 0.002; WTd50 vs. PEd50 p = 0.001; Figure S1B) This effect was mainly
driven by lowered maternal body weight of the PE group, which was mainly due to the
lowered number and weights of pups and placentas in the PE group [35].
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2.2. Altered Expression of Kidney Injury Marker Genes
Genes specific for tubular injury, angiogenesis, fibrosis, tissue inflammation, or oxida-
tive stress were selected in a hypothesis-based manner and analyzed during and after PE
and WT pregnancy. Most significant alterations in renal gene expression were detected
during preeclamptic pregnancy (Figure 2A). The expression of specific tubular injury mark-
ers, kidney injury molecule 1 (Kim-1, Figure 2B), and neutrophil gelatinase associated lipocalin
2 (Ngal, Figure 2C) was significantly 2.5-fold increased during preeclamptic rat pregnancy.
Nephrin (Nphs-1), which is part of the podocyte slit diaphragm, is similarly expressed in
PE and WT rats during pregnancy, suggesting no damage in the slit membrane. Most genes
that are associated with angiogenesis and vasoconstriction were similarly expressed during
preeclamptic pregnancy in the kidney. Neither endothelin-1 (Et-1), vascular endothelial
growth factor (Vegf-a), nor their receptors (Flt-1, Flk-1, sFlt-1) showed significantly altered
gene expression during pregnancy. To identify fibrotic alterations in the kidney tissue,
marker genes such as collagen type 1 and 4 (Col-1, Col4α-1), connective tissue growth
factor (Ctgf ) and transforming growth factor beta 1 (Tgfβ-1) were measured. Col-1 and
Ctgf were significantly altered during preeclamptic pregnancy (Figure 2A,D). The specific
marker genes CD68 (cluster of differentiation 68 molecule) and Mcp-1 (monocyte chemoat-
tractant protein 1) were used to characterize inflammatory processes. CD68 expression
was significantly increased during preeclamptic pregnancy compared to WT. Markers for
renal oxidative stress include components of the NADPH oxidase 2 (Ncf-1, Ncf-4, Cyb-a,
Cyb-b) and the renal-specific NADPH oxidase 4 (Nox-4). Ncf-4 expression was slightly but
significantly increased during PE (Figure 2E).
When focusing on the gene expression after preeclamptic pregnancy, only few signifi-
cant differences were present (Figure 2A). The inflammation marker CD68 was significantly
increased after preeclamptic pregnancy compared to WT postpartum. Genes associated
with nephron injury, angiogenesis and vasoconstriction, and fibrosis were similarly ex-
pressed in PE and WT rats after pregnancy. The oxidative stress marker Ncf-4 continued to
show a slightly higher expression in PE rats compared to WT postpartum (Figure 2E). In ad-
dition, the Nox-4 expression was significantly increased in PE rats postpartum (Figure 2F).
Gene expression- and p-values are shown in Table S2.
2.3. Mild Structural Renal Impairment
Enlargement of glomeruli and increased capillary wall thickening, the hallmark of
glomerular endotheliosis, go along with albuminuria in human and rat preeclamptic
pregnancy [13,17,27]. First, we assessed the glomerular damage during preeclamptic rat
pregnancy and determined features of glomeruli such as size and density. The glomerular
size was not changed during PE pregnancy in histologic analysis (Figure 3A). Through the
characterization of the glomerular capillary area, capillary wall thickening and glomerular
sclerosis could be detected. PE rats had higher percentage of periodic acid–Schiff (PAS)-
positive area (WTd21 vs. PEd21, p = 0.0293; Figure 3B). The renal tubular system is crucial
for a physiologically functioning kidney. Evaluation of the tubular damage in preeclamptic
rats was performed by analyzing the tubular injury score, inflammation, and perivascular
fibrosis. The tubular system was not significantly altered during PE pregnancy, yet there
was a tendency of mild tubular injury during these pregnancies. Renal tubular dilation,
and brush border thinning were observed (Figure 3C). Inflammation was quantified by
macrophage count in the renal medulla. The comparison revealed no significant difference
during pregnancy, although PE rats showed higher, yet not significant numbers of CD68-
positive cells, ranging between 10 and 50 per field of view (Figure 3D). The relative fibrotic
area was calculated to quantify perivascular fibrosis, though the vessels in PE and WT rats
appeared similar during pregnancy (Figure 3E).
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Figure 2. Renal injury marker expres ion was altered during and slightly after reecl ti -
nancy. (A) Descriptive overvie of hypothesis-driven relative gene expression in kidney tissue
during preeclamptic (PE) and control (WT) pregnancy (day 21) and postpartum (day 50). Analyzed
genes are marker for nephron injury, angiogenesis, inflammation, fibrosis, and oxidative stress (from
top to bottom). Legend indicates means of relative gene expression normalized to 18S expression.
(B–F) Marker genes that show altered expression in the PE group are emphasized. (B,C) Nephron
injury marker kidney injury molecule-1 (Kim-1) and neutrophil gelatinase-associated lipocalin 2 (Ngal)
were elevated during preeclamptic pregnancy compared to WT. (D) Fibrosis marker connective tissue
growth factor (Ctgf ) expression was slightly increased during preeclamptic pregnancy. (E,F) Oxida-
tive stress marker expression of neutrophil cytosolic factor 4 (Ncf-4) and NADPH oxidase 4 (Nox-4)
was higher during and/or after preeclamptic pregnancy. All genes are normalized to 18s expression.
Statistical analysis was performed using a two-way ANOVA. Bars are indicated as mean ± SD
(n = 5–7). p-value is shown in comparison to respective controls as * p ≤ 0.05; *** p ≤ 0.001.
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ten fields of view per kidney. Representative images of immunohistochemically stained kidney sections for WT and PE
were counterstained with DAPI (blue). Primary mouse anti-rat CD68 antibody (clone ED1) and secondary Cy3-conjugated
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In addition, a characterization of the glomerular and tubular damage was performed
in kidneys after pregnancy of PE and WT rats. The glomerular tuft area was increased
in both groups postpartum; however, in comparison to WT, glomeruli were significantly
enlarged (WTd50 vs. PEd50, p = 0.0406; Figure 3A). The glomerular tuft area was not altered
postpartum in PE rats compared to WT rats (Figure 3B). The tendency for renal tubular
damage was present in kidneys from PE rats after pregnancy, although not significantly
different (Figure 3C). Similar to the observations during pregnancy, the kidneys of PE rats
postpartum displayed more CD68+ cells per field of view, but the comparison was not
significant (Figure 3D). There were no significant differences postpartum in perivascular
fibrosis between PE and WT rats (Figure 3E).
2.4. Renal Function Is Slightly Altered in PE Pregnancy
The urine parameters were measured to characterize kidney filtration and excretion.
Upon renal injury the reabsorption could be influenced. In a group-wise comparison,
urinary creatinine was significantly reduced during and after preeclamptic pregnancy
compared to WT and in the PE group on d19 compared to d49 (each comparison with
p < 0.0001; Figure 4B).
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of urine creatini e (A), sodium (B), potassium (C), and chlori e (D) ar displayed per day. All
parameters were reduced on day 19 of preeclamptic pregnancy (PE) compared to respective controls
(WT). Urine creatinine was less reduced in PE on day 49. Sodium, potassium, and chloride recovered
after PE pregnancy. Statistical analysis was done with a two-way ANOVA. Mean ± SD is indicated
(n = 7–8). p-value is shown * p ≤ 0.05; ** p ≤ 0.01; **** p ≤ 0.0001.
Similarly, sodium was significantly lower in PE d19 compared to PE d49 (p = 0.0263;
Figure 4C). Of the electrolytes measured, only potassium and hloride concentr tions
wer significantly affected during pr eclamptic p egnancy (K+ p = 0.0063; Cl− p = 0.0034;
Figure 4D,E). In addition, potassium wa significantly lower in WT d19 comp red to WT
d49 (K+ p = 0.0042; Figure 4D). Noticeably, PE a s had higher urine xcretion compared to
pregnant WT or postpartum.
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3. Discussion
We investigated the effect of PE on the kidney in a transgenic rat model and analyzed
whether the renal alterations manifested postpartum. During PE, renal gene expression
was altered. Mild glomerular alterations with increased glomerular density and tubular
changes were present. Increased albumin excretion could be detected. Altered expression
was present in marker genes associated with nephron injury (Kim-1, Ngal), fibrosis (Col-1,
Ctgf ), inflammation (CD68), and oxidative stress (Ncf-4). The expression of the tubular
injury biomarker Kim-1 [36] was elevated during PE and returned to normal after pregnancy,
indicating kidney damage only during PE. Only mild 2.5-fold increase of Ngal expression
was detected, whereby others reported a rapid 1000-fold increase upon tubular injury [37].
We observed mild changes in the expression of oxidative stress marker genes (Ncf-4, Nox-4)
in the kidney during PE. These observations go along with studies that outline elevated ROS
and impaired mitochondrial function in pregnancy in the kidney of other PE models [28,30].
It has been shown that agonistic autoantibodies (AT1-AA), which occur in the plasma of
preeclamptic women, are associated with ROS production in different tissues including
the kidney [28,38]. In our rat model for PE, most renal alterations recovered postpartum.
Only oxidative stress marker genes (Ncf-4, Nox-4), mild glomerular enlargement, and
decreased creatinine excretion persisted after PE. The maternal bodyweight was reduced
during PE due to lower placental and fetal weights but not different postpartum as shown
before [34,35]. Therefore, we assume that alterations in creatinine excretion did not result
from differences in muscle mass but moreover from impaired renal function.
We hypothesized that a preeclamptic pregnancy alone is not sufficient to predispose
renal damage and influences further cardiovascular damage, as observed in humans.
Most studies of other PE animal models show renal alterations during pregnancy, such as
glomerular enlargement, fibrosis, glomerulosclerosis, and proteinuria [39–42]. However,
only few focus on the post-pregnancy effects of PE on the kidney. In the RUPP model, BP
and albuminuria recurred eight weeks after delivery, and no glomerular or tubular damage
was detectable [31]. In Dahl salt-sensitive rats, glomerular and tubular injuries were
present in female rats eight weeks after giving birth, detected as increased protein levels of
nephrin and KIM-1 in the urine [43]. Together with our findings, these results support the
evidence that persisting high blood pressure could be a cause for kidney damage observed
in humans after preeclamptic pregnancy. In addition, the pressure dependency of kidney
damage has been highlighted by Mori et al. They used an angiotensin II-induced model of
hypertension, in which the kidney was protected from most renal injuries (fibrosis, tubular
damage) when high renal arterial pressure was regulated by chronic servo-control [44].
These findings support our understanding that the pregnancy-associated renal injury in PE
depends on the reversibility of pregnancy-related hypertension in PE.
Our initial hypothesis was driven by observations in women with a history of PE,
who showed a higher risk for the development of ESRD or CKD later in life [12,45].
The majority of women had no kidney function test before PE [45]. Our results show
evidence that PE alone might not be sufficient to cause renal disease. Dai et al. state that
women with previously existing hypertension superimposed by PE had the highest risk
of developing ESRD compared to those with either pre-existing hypertension or PE [20].
Kattah et al. showed that women with a history of PE had a four times higher risk to develop
ESRD and 20% of them showed decreased kidney function before pregnancy [21]. These
studies underline the potential role of previously undetected hypertension resulting in
superimposed PE contributing to renal disease. Moreover, we suggest that the development
of renal disease following preeclamptic pregnancy is due to multiple diseases affecting
the renal function. According to a multiple-hit hypothesis, two or more events would
contribute to the development of renal disease and PE might be only one contributor.
Our study displays limitations regarding the experimental procedure because we
included two timepoints, at the end of pregnancy and postpartum. Organs were harvested
and analyzed from both timepoints, respectively, but longitudinal BP measurement could
only be performed for those sacrificed postpartum. Both groups presented comparable BP
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values during pregnancy. In addition, the longitudinal BP was only measured occasionally
in WT to fulfil the 3R principle in animal experiments. Previous studies of our group
showed that WT rats do not develop hypertension during pregnancy [34].
In conclusion, the transgenic rat model for PE showed mild renal impairment during
pregnancy that mostly resolved postpartum. Minor renal injury with elevation of oxidative
stress biomarkers and alterations of glomerular filtration were present during preeclamptic
rat pregnancy. These results pointed out a slight damage of the kidney after preeclamptic
pregnancy and therefore could not completely exclude PE as a risk factor for postpartum
renal disease. We suspect that additional events affecting the renal function would be
necessary for renal damage and subsequent failure.
4. Materials and Methods
4.1. Animal Study
Female SD rats transgenic for the human angiotensinogen gene (Tg(hAgt)L1623)
were mated with male SD rats transgenic for the human renin gene (Tg(hRen)L10J) as
previously described [32,35]. Female rats were controlled daily for a vaginal plug, which
was presumed the first day of pregnancy (d1). Pregnant transgenic female rats resulting
from the crossing of transgenic animals developed a typical preeclamptic phenotype (PE)
with hypertension and albuminuria and were used for the experimental procedure [32].
SD wild-type (WT) females and males were crossed and served as a control. All rats were
kept under standard conditions with controlled temperature of 22 ± 2 ◦C, humidity of
55 ± 15% and a 12:12 h light–dark cycle. The animals had food (Sniff V1324-300) and water
ad libitum throughout the experiment. Rats were sacrificed at two different endpoints, the
end of pregnancy (day 21, n = 9WT; 8PE) and four weeks postpartum pregnancy (day 50,
n = 9WT; 11PE) by decapitation under deep isoflurane anesthesia, the latter time-point
corresponding to approx. two years in humans [46]. Organs and blood were collected and
stored at −80 ◦C until further used. The renal capsule, fat pad, and adrenal glands were
detached from the kidney, which was transversely cut in half for further analysis. The study
has been approved by local authorities (State Office of Health and Social Affairs, Berlin).
4.2. Blood Pressure Measurement
DSI telemetry devices (HD-T11) were implanted under inhalation anesthesia with
isoflurane (isoflurane–air composite 2–2.5%) 14 days before mating as previously de-
scribed [34]. Thus, the blood pressure (BP) could be measured before, during, and post-
partum pregnancy in 5-minute intervals on a regular basis. Animals were single-housed
during BP recordings.
4.3. Urine Measurement
The 24-hour urine was collected during pregnancy on day 19 and after pregnancy on
day 49 as previously described [47]. Urine samples were analyzed with the AU480 clinical
chemistry analyzer (Beckman Coulter) following the manufacturer’s instructions. For
albumin concentration measurement a direct, competitive ELISA (CellTrend, Luckenwalde,
Germany) was performed. The amounts of chloride, potassium, and sodium were detected
using ion-selective electrodes. Creatinine was enzymatically converted and colorimetrical
quantified (No. OSR61204, Beckman Coulter, Krefeld, Germany). All urine parameters
were normalized to either diuresis or creatinine concentration.
4.4. Gene Expression Analysis
Gene expression analysis was performed as previously described [48]. Briefly, frozen
kidney tissue was homogenized with Qiazol Lysis Reagent (Qiagen) and Precellys ceramic
beads (Peqlab Biotechnology, Erlangen, Germany). Total RNA was isolated using the
RNeasy Mini Kit (Qiagen, Hilden, Germany) following the manufacture’s protocol. The
High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Waltham, USA)
was used following the manufacture’s protocol to reverse-transcribe two micrograms of
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mRNA into complementary DNA (cDNA). To quantify the relative gene expression, a
reverse-transcription quantitative polymerase chain reaction (RT-qPCR) was performed
using the QuantStudio 3 Real-Time PCR System (Applied Biosystems) with either TaqMan
Fast Universal PCR Master Mix or Fast SYBR Green Master Mix (both Thermo Fisher
Scientific, Waltham, MA, USA). Primer and probes were designed using Primer Express
3.0 and synthesized by BioTez, Germany (primer sequences: Table S1). Primers were
diluted to a final concentration of 10 mM, probes to 5 mM. The target mRNA expression
was quantitively analyzed with the standard curve method. All expression values were
normalized to the housekeeping gene 18S. The genes were selected in a hypothesis-based
manner prior analysis.
4.5. Immunohistochemistry
Kidney slices were fixed in 4% formalin (24 h), dehydrated, and embedded in paraffin.
The kidneys were cut transversely into 2- and 4-µm-thick slices with an electronic rotary
microtome (Thermo Fisher). Kidney slices were stained and scanned simultaneously using
the Slide Scanner Panoramic MIDI with the objective plan-apochromat 20×/0.8× (Zeiss) to
guarantee comparability as previously described [35]. The hemalaun–eosin (HE) staining
was done following the manufactures protocol (T865, Carl Roth, Karlsruhe, Germany).
The circumference of the glomerular-capillary tuft area within three cortical fields of view
per kidney (n = 5) were measured to identify glomerular endotheliosis. Semi-quantitative
analysis of tubular damage was performed using the previously described injury score [49].
Fifteen medullar images (200×magnification) were scored in a blinded manner regarding
the percentage of tubular dilation, degeneration, necrosis, cast formation, and loss of
brush border. Periodic acid–Schiff (PAS) staining was used to detect carbohydrate-rich
components (glycogen) in the glomeruli. The slides were incubated in 0.5% periodic
acid (Sigma Aldrich, 5 min., Steinheim, Germany ), rinsed, and Schiff’s reagent (Merck,
Darmstadt, Germany ) was applied (10-min darkness). The slides were counterstained
with hemalaun (Carl Roth, 5 min). The PAS-positive area of 8–10 glomerular areas per
kidney (n = 5) was measured using the color threshold plug-in of ImageJ [50]. Masson–
Goldner trichrome (MGT) staining was used to measure perivascular fibrosis. Kidney
slides (2 µm) were stained in accordance with the manufacture’s protocol (3459, Carl
Roth). The perimeter of the connective tissue, vessel, and lumen of three well-framed
arteries per kidney were measured. The fibrotic area was calculated in relation to the total
vessel area. Macrophages in the kidney tissue were stained with mouse anti-rat CD68
antibody (clone ED1; No. MCD341R, Bio-Rad, conc. 1:100) [51,52]. The secondary Cy3-
conjugated donkey anti-mouse-IgG antibody (No. 715-165-151, Jackson ImmunoResearch)
was used (conc. 1:300) and nuclei were stained with Vectashield mounting medium with
DAPI (4′,6-diamidin-2-phenylindol; No. H-1200; Vector Laboratories, Burlingame, USA).
CD68-positive cells were manually counted in ten fields of view (magnification 200×) per
kidney (n = 5), when a nucleus was colocalized to a Cy3 signal. Histological analysis was
performed in a blinded manner using the software case viewer (3D Histech Ltd., Budapest,
Hungary) and Image J (National Institute of Health, Bethesda, MD, USA).
4.6. Statistics
Statistical analysis was performed using the software GraphPad Prism 6 and 7. Values
are presented as mean ± standard deviation (SD). Results are displayed as n = 8–11
per treatment group and timepoint. Outliers were identified with the ROUT method
using a maximum false discovery rate of 1%, values tested for Gaussian distribution and
comparison of groups was done with an ordinary two-way ANOVA (analysis of variance)
with a Sidak’s multiple comparison test. The f-value is indicated with respective degrees of
freedom. p-values are indicated as * ≤ 0.05, ** ≤ 0.01, *** ≤ 0.001, **** ≤ 0.0001.
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